What is Forest Devices?
Founded in 2015 and based in Pittsburgh, Forest Devices is dedicated to revolutionizing stroke diagnosis with its AlphaStroke device. This pioneering technology is engineered to detect stroke in any environment, aiming to expedite patient treatment and significantly reduce the long-term disability associated with stroke. The company's mission is deeply rooted in improving patient outcomes through faster and more accessible diagnostic tools, positioning it as a key player in the medtech innovation landscape.
How much funding has Forest Devices raised?
Forest Devices has raised a total of $3.7M across 3 funding rounds:
Debt
$1.3M
Angel/Seed
$2.3M
Debt
$131K
Debt (2017): $1.3M, investors not publicly disclosed
Angel/Seed (2018): $2.3M led by Innovation Works
Debt (2021): $131K supported by PPP
Key Investors in Forest Devices
Innovation Works
Innovation Works is a prominent regional seed-stage investment fund and business incubator, likely focusing on technology startups within the Pittsburgh area and supporting their growth from inception through early-stage development.
What's next for Forest Devices?
The recent major strategic investment signals a critical growth phase for Forest Devices. This capital infusion is expected to accelerate the commercialization of AlphaStroke, potentially expanding manufacturing capabilities, broadening market reach, and further investing in research and development. The company's focus on a critical unmet need in emergency medicine suggests a trajectory aimed at widespread adoption and integration into standard emergency response protocols, marking a significant step towards achieving its mission of faster stroke treatment.
See full Forest Devices company page
